Logo image of ESRT

EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ESRT - US2921041065 - REIT

6.515 USD
+0.14 (+2.28%)
Last: 1/21/2026, 12:00:09 PM
Fundamental Rating

4

Taking everything into account, ESRT scores 4 out of 10 in our fundamental rating. ESRT was compared to 125 industry peers in the Diversified REITs industry. ESRT has an average financial health and profitability rating. ESRT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ESRT was profitable.
  • In the past year ESRT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ESRT reported negative net income in multiple years.
  • In the past 5 years ESRT always reported a positive cash flow from operatings.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • ESRT has a Return On Assets (0.85%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 3.25%, ESRT perfoms like the industry average, outperforming 56.80% of the companies in the same industry.
  • ESRT's Return On Invested Capital of 2.87% is in line compared to the rest of the industry. ESRT outperforms 54.40% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ESRT is in line with the industry average of 3.07%.
  • The last Return On Invested Capital (2.87%) for ESRT is above the 3 year average (2.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROIC 2.87%
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

  • ESRT has a Profit Margin (4.55%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of ESRT has declined.
  • Looking at the Operating Margin, with a value of 18.68%, ESRT is in line with its industry, outperforming 44.80% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ESRT has remained more or less at the same level.
  • The Gross Margin of ESRT (54.04%) is worse than 73.60% of its industry peers.
  • In the last couple of years the Gross Margin of ESRT has remained more or less at the same level.
Industry RankSector Rank
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

4

2. Health

2.1 Basic Checks

  • ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ESRT has more shares outstanding
  • The number of shares outstanding for ESRT has been reduced compared to 5 years ago.
  • Compared to 1 year ago, ESRT has a worse debt to assets ratio.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.58, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
  • ESRT has a Altman-Z score (0.58) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.92 is on the high side and indicates that ESRT has dependencies on debt financing.
  • ESRT has a Debt to Equity ratio of 1.92. This is in the lower half of the industry: ESRT underperforms 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACC0.47
WACC6.06%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ESRT has a Current Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • ESRT has a better Current ratio (2.59) than 89.60% of its industry peers.
  • A Quick Ratio of 2.59 indicates that ESRT has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.59, ESRT belongs to the top of the industry, outperforming 89.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

  • ESRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.50%, which is quite impressive.
  • ESRT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.83% yearly.
  • Looking at the last year, ESRT shows a small growth in Revenue. The Revenue has grown by 0.45% in the last year.
  • The Revenue has been growing slightly by 0.98% on average over the past years.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%

3.2 Future

  • The Earnings Per Share is expected to decrease by -37.27% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 1.75% on average over the next years.
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.40 indicates a rather cheap valuation of ESRT.
  • ESRT's Price/Earnings ratio is rather cheap when compared to the industry. ESRT is cheaper than 95.20% of the companies in the same industry.
  • ESRT is valuated cheaply when we compare the Price/Earnings ratio to 26.94, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 106.45, ESRT can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ESRT is on the same level as its industry peers.
  • ESRT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.94.
Industry RankSector Rank
PE 7.4
Fwd PE 106.45
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESRT is valued cheaper than 91.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.98
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • ESRT's earnings are expected to decrease with -56.74% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%

3

5. Dividend

5.1 Amount

  • ESRT has a Yearly Dividend Yield of 2.19%.
  • In the last 3 months the price of ESRT has falen by -20.08%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 6.59, ESRT's dividend is way lower than its industry peers. On top of this 84.80% of the companies listed in the same industry pay a better dividend than ESRT!
  • Compared to an average S&P500 Dividend Yield of 1.83, ESRT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.19%

5.2 History

  • The dividend of ESRT decreases each year by -17.38%.
  • ESRT has paid a dividend for at least 10 years, which is a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • ESRT pays out 79.65% of its income as dividend. This is not a sustainable payout ratio.
  • ESRT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP79.65%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (1/21/2026, 12:00:09 PM)

6.515

+0.14 (+2.28%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29
Earnings (Next)02-17
Inst Owners100.46%
Inst Owner Change-0.12%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.11B
Revenue(TTM)766.65M
Net Income(TTM)34.89M
Analysts75
Price Target8.12 (24.64%)
Short Float %4.06%
Short Ratio4.91
Dividend
Industry RankSector Rank
Dividend Yield 2.19%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP79.65%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.01%
PT rev (3m)-10.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 7.4
Fwd PE 106.45
P/S 1.45
P/FCF N/A
P/OCF 4.18
P/B 1.03
P/tB 4.04
EV/EBITDA 8.98
EPS(TTM)0.88
EY13.51%
EPS(NY)0.06
Fwd EY0.94%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)1.56
OCFY23.92%
SpS4.5
BVpS6.31
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.18
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROCE 3.64%
ROIC 2.87%
ROICexc 2.99%
ROICexgc 3.79%
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
FCFM N/A
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ROICexc(3y)2.99%
ROICexc(5y)2.46%
ROICexgc(3y)3.81%
ROICexgc(5y)3.15%
ROCE(3y)3.48%
ROCE(5y)2.83%
ROICexgc growth 3Y18.9%
ROICexgc growth 5Y-2.68%
ROICexc growth 3Y19.87%
ROICexc growth 5Y-1.77%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA 6.18
Cap/Depr 140.72%
Cap/Sales 34.79%
Interest Coverage 1.49
Cash Conversion 79.7%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 0.58
F-Score6
WACC6.06%
ROIC/WACC0.47
Cap/Depr(3y)133.09%
Cap/Depr(5y)115.91%
Cap/Sales(3y)34.64%
Cap/Sales(5y)32.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%
EBIT growth 1Y-8.53%
EBIT growth 3Y22.28%
EBIT growth 5Y0.51%
EBIT Next Year124.48%
EBIT Next 3Y34.61%
EBIT Next 5Y20.13%
FCF growth 1Y96.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.72%
OCF growth 3Y7.08%
OCF growth 5Y2.32%

EMPIRE STATE REALTY TRUST-A / ESRT FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status for ESRT stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


What is the profitability of ESRT stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 4 / 10.


What is the valuation of EMPIRE STATE REALTY TRUST-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMPIRE STATE REALTY TRUST-A (ESRT) is 7.4 and the Price/Book (PB) ratio is 1.03.


What is the financial health of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.